HOWL (Werewolf Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Werewolf Therapeutics, Inc. Common Stock (HOWL) is a publicly traded Healthcare sector company. As of May 21, 2026, HOWL trades at $0.44 with a market cap of $24.07M and a P/E ratio of -0.34. HOWL moved +3.43% today. Year to date, HOWL is -32.03%; over the trailing twelve months it is -61.58%. Its 52-week range spans $0.40 to $4.18. Rallies surfaces HOWL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find HOWL SEC filings?

Rallies organizes HOWL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

HOWL Key Metrics

Key financial metrics for HOWL
MetricValue
Price$0.44
Market Cap$24.07M
P/E Ratio-0.34
EPS$-1.32
Dividend Yield0.00%
52-Week High$4.18
52-Week Low$0.40
Volume7.49K
Avg Volume0
Revenue (TTM)$0
Net Income$-60.82M
Gross Margin0.00%

Latest HOWL News

Recent HOWL Insider Trades

  • EVNIN LUKE sold 85.89K (~$36.93K) on May 20, 2026.
  • EVNIN LUKE sold 62.97K (~$28.34K) on May 19, 2026.
  • EVNIN LUKE sold 22.18K (~$11.09K) on May 18, 2026.

HOWL Analyst Consensus

HOWL analyst coverage data. Average price target: $0.00.

Common questions about HOWL

Where can I find HOWL SEC filings?
Rallies organizes HOWL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show HOWL 10-K and 10-Q filings?
Rallies organizes HOWL SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is HOWL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HOWL. It does not provide personalized investment advice.
HOWL

HOWL